“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Opinion | Something is fundamentally wrong with global public health. More accurately, something is fundamentally wrong with the mindset of global health professionals, particularly those in positions of leadership. It has become normal to speak, repeat, and defend complete absurdity, as if illusions and fantasies are real. There are no sanctions for operating in this […]
A new study published in the journal Vaccine revealed there was a much higher risk of serious adverse events of special interest for randomized clinical trial participants who received a messenger RNA (mRNA) COVID-19 biologic when compared to participants, who received a placebo for both the Pfizer/BioNTech mRNA BNT162b2 (also known as “Comirnaty”) COVID shot […]
On Feb 2, 2021, Tanzania’s health minister, Dorothy Gwajima, announced that her country has no plans in place to recommend widespread use of COVID-19 vaccines in the African country.1 The announcement came a few days after Tanzania’s President John Magufuli expressed concern about the safety and effectiveness of COVID-19 vaccines developed and manufactured in Western […]
The University of Oxford’s Jenner Institute and Oxford Vaccine Group in the United Kingdom has announced that its researchers have begun recruiting children aged five to 12 years for phase II and phase III clinical trials testing an experimental COVID-19 vaccine the university is developing in partnership with AstraZeneca plc.1 Oxford’s ChAdOx1 nCov-19 (“chimpanzee adenovirus […]
In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]
Vaccine developers at the University of Pittsburgh’s Center for Vaccine Research (CVR) have taken a part of the coronavirus involved in COVID-19 infection and attached it to a genetically modified measles vaccine that has been used for many years.1 According to CVR Director Dr. Paul Duprex, “CVR has a mandated role to respond rapidly to […]
Story Highlights In light of the coronavirus outbreak, three research teams have been awarded grants by the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the novel coronavirus. In a public-private partnership with NIH, Moderna, Inc. is using an experimental mRNA technology to develop a vaccine. Johnson & Johnson and other drug companies […]